155 related articles for article (PubMed ID: 12515928)
1. [Macro-economic calculation of spending versus micro-economic follow-up of costs of breast cancer].
Borella L; Paraponaris A
Rev Epidemiol Sante Publique; 2002 Dec; 50(6):581-92. PubMed ID: 12515928
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
3. [Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre].
Lilliu H; Stevens D; Brun C; Morel J; Pen CL; Bonastre J; Bachelot F; Davesne C; Gentile A; Hirlimann E; Sabourin JC; Berlie J; Rouëssé J
Bull Cancer; 2002 Jun; 89(6):635-42. PubMed ID: 12135864
[TBL] [Abstract][Full Text] [Related]
4. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
5. A health economic evaluation of follow-up after breast cancer surgery: results of an rct study.
Koinberg I; Engholm GB; Genell A; Holmberg L
Acta Oncol; 2009; 48(1):99-104. PubMed ID: 18766474
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of cancer treatment costs: another tool for oncology managers.
Chirikos TN; Ruckdeschel JC; Krischer JP
J Oncol Manag; 2001; 10(3):11-7. PubMed ID: 11548179
[TBL] [Abstract][Full Text] [Related]
7. Economic outcomes of breast cancer survivorship: CALGB study 79804.
Hensley ML; Dowell J; Herndon JE; Winer E; Stark N; Weeks JC; Paskett E
Breast Cancer Res Treat; 2005 May; 91(2):153-61. PubMed ID: 15868443
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer: we do need primary cost data.
Bonastre J; Jan P; Barthe Y; Koscielny S
Breast; 2012 Jun; 21(3):384-8. PubMed ID: 22520336
[TBL] [Abstract][Full Text] [Related]
9. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
Marchetti M; Caruggi M; Colombo G
Clin Ther; 2004 Sep; 26(9):1546-61. PubMed ID: 15531017
[TBL] [Abstract][Full Text] [Related]
10. Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.
Ihbe-Heffinger A; Paessens BJ; von Schilling C; Shlaen M; Gottschalk N; Berger K; Bernard R; Kiechle M; Peschel C; Jacobs VR
Onkologie; 2011; 34(5):241-6. PubMed ID: 21577029
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
Chevalier J; Bonastre J; Avril MF
Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
[TBL] [Abstract][Full Text] [Related]
12. Economic analysis of psychosocial group therapy in women with metastatic breast cancer.
Lemieux J; Topp A; Chappell H; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2006 Nov; 100(2):183-90. PubMed ID: 16773438
[TBL] [Abstract][Full Text] [Related]
13. [The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system].
Perrier L; Borella L; Philip T
Bull Cancer; 2003 Nov; 90(11):1005-9. PubMed ID: 14706905
[TBL] [Abstract][Full Text] [Related]
14. [Cost effectiveness evaluation of breast cancer therapy. Comparative analysis 1975-1985 in a cancer prevention center].
Lapeyre-Mestre M; Daly-Schveitzer N; Boussin G; Delande G
Rev Epidemiol Sante Publique; 1993; 41(5):397-406. PubMed ID: 8284480
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation.
Grunfeld E; Gray A; Mant D; Yudkin P; Adewuyi-Dalton R; Coyle D; Cole D; Stewart J; Fitzpatrick R; Vessey M
Br J Cancer; 1999 Mar; 79(7-8):1227-33. PubMed ID: 10098764
[TBL] [Abstract][Full Text] [Related]
16. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
Shih YC; Xu Y; Cormier JN; Giordano S; Ridner SH; Buchholz TA; Perkins GH; Elting LS
J Clin Oncol; 2009 Apr; 27(12):2007-14. PubMed ID: 19289624
[TBL] [Abstract][Full Text] [Related]
17. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
[TBL] [Abstract][Full Text] [Related]
18. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
19. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
20. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
